Safety and Efficacy of Emixustat in Stargardt Disease
Stargardt Disease 1 / Posted 1 year ago
The purpose of this study is to determine if emixustat hydrochloride reduces the rate of progression of macular atrophy compared to placebo in subjects with Stargardt disease.
- Study start date : 01/11/2018
- Study end date : 01/02/2022
- Wales-Based Study Contact : please speak to your clinician